Setareh Seyedkazemi, CHIEF DEVELOPMENT OFFICER at Adverum Biotechnologies, Inc. (ADVM), sold 924 shares at $2.00 ($2K) on 2025-05-15, disclosed to the SEC on 2025-05-16.
Open-market sale of $2k ADVM by CHIEF DEVELOPMENT OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADVM | BUY | 2022-05-24 | $17K | — | Filing → |